Call for Abstract

20th World Congress on Advances in Pharmaceutical Sciences, will be organized around the theme “Latest Discoveries in Pharmaceutical Sciences”

Pharma Sci 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharma Sci 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The pharmaceutical sciences combine a broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical sciences can be broadly classified into the following main categories, with many specialized fields within each category.

Over the years, pharmaceutical scientists have been instrumental in discovering and developing innovative drugs that save thousands of people’s lives and improve the quality of life for many others. Pharmaceutical scientists can pursue a variety of jobs. They are employed by pharmaceutical companies, they work as pharmacists, doctors, and as researchers and professors at universities, as regulatory scientists for agencies like the Food and Drug Administration (FDA), and as researchers at national laboratories such as the National Institutes of Health (NIH).

  • Track 1-1Advancements in pharmaceutical technology
  • Track 1-2Pharmacological vitality of drugs
  • Track 1-3Pharmacotherapy
  • Track 1-4Neuropharmacology
  • Track 1-5Pharmacokinetics and Pharmacodynamics
  • Track 1-6Applications of Pharmaceutical Nanotools

Pharmaceutical chemistry involves in Drug Discovery and Design, deals with the design and synthesis of new drug molecules. This category includes specialized fields of study such as medicinal chemistry, combinatorial chemistry, structural biology, identification of biological targets, and assay development to test drug candidates.

Drug Analysis involves separating, identifying, and quantifying the components of a sample. Analytical chemistry is an important component of all areas of the pharmaceutical sciences.


  • Track 2-1Drug Design
  • Track 2-2Drug Discovery and Development
  • Track 2-3New Drug Life Cycle

Pharmacology is the science of drugs and their effect on living systems. You can find pharmacology present everywhere. In medicine cabinets, when you visit the dentists and when you take any type of medication. Pharmacology is also responsible for painkillers, caffeine drinks and antibiotics. It is the science of what is happening to your body and to the drug itself.

Every medication we take alters the chemistry within our body. The role of pharmacology is to understand why these changes are happening, allowing us to develop better drugs.

Pharmacological knowledge improves the lives of millions of people across the world. It maximizes their benefit and minimizes risk and harm. As new diseases emerge, and older medicines - like antibiotics - no longer work as well, the contribution of pharmacology to finding better and safer medicines becomes more vital.


  • Track 3-1Pharmacokinetics and Pharmacodynamics
  • Track 3-2Drugs Mechanism of Action
  • Track 3-3Research on Drug Adverse Reactions

Drug Action examines how the drug itself works in a living system, which is the definition of pharmacology. The action of the drug can be studied at the molecular level, in a cell, an organ, and in animals. Specialty fields within Drug Action include molecular biology, pharmacology, pharmacodynamics, toxicology, and biochemistry.


  • Track 4-1Herbal Drugs, research
  • Track 4-2Research developments in Pharmacognosy
  • Track 4-3Extraction of drugs from plants

Pharmaceutics is the discipline of pharmacy that deals with all facets of the process of turning a new chemical entity (NCE) into a medication able to be safely and effectively used by patients in the community. Pharmaceutics is the science of dosage form design. There are many chemicals with known pharmacological properties, but a raw chemical is of no use to a patient. Pharmaceutics deals with the formulation of a pure drug substance into a dosage form. Branches of pharmaceutics include: Pharmacokinetics, Pharmacodynamics, Pharmacoepidemiology, Pharmacogenomics, Pharmacovigilance, Pharmaceutical formulation and Pharmaceutical technology.


  • Track 5-1Drugs Manufacturing
  • Track 5-2New Chemical Entity
  • Track 5-3Manufacturing Equipments and advancements

Pharmaceutical Analysis is an Analytical Method used to determination the quality and quantity of the pharmaceutical products. It also gives the information about the purity and safety of the products. Briefly it can be described as it identifies, determines, quantifies, purifies and separates the active compound from the mixture.


  • Track 6-1Pharmaceutical Analysis and processes
  • Track 6-2DNA Analysis
  • Track 6-3Human drug metabolism
  • Track 6-4Electrochemical method

Regulatory Affairs promotes communication, understanding, and cooperation between scientists from industry and academia and the regulatory authorities worldwide who govern approval and distribution, by means of developing regulatory guidelines.

More and more, these categories are beginning to overlap. For example, a scientific engineer working in Drug Delivery needs to understand how toxicology affects Drug Action, and a chemist working in Drug Discovery and Design must know about the pharmacokinetics of Drug Delivery. For this reason, pharmaceutical scientists are required to have a broad base of knowledge in a variety of sciences.


  • Track 7-1Application of regulatory science
  • Track 7-2Regulatory engineering
  • Track 7-3Regulatory economics
  • Track 7-4Science in legislation and in courts

Clinical Sciences are concerned with the use of drugs in the treatment of diseases. Properties of new drugs — such as efficacy, adverse effects, drug-to-drug interaction, bioavailability — are determined in clinical trials in humans.


  • Track 8-1Clinical Pharmacy and its Role in Treatment
  • Track 8-2Healthcare Pharmacy
  • Track 8-3Clinical Pharmacy & Toxicology
  • Track 8-4Healthcare Patient Safety
  • Track 8-5Pharmacist role in Healthcare system

Nanotechnology is manipulation of matter on an atomic, molecular, and supramolecular scale. The earliest, widespread description of nanotechnology referred to the particular technological goal of precisely manipulating atoms and molecules for fabrication of macroscale products, also now referred to as molecular nanotechnology. A more generalized description of nanotechnology was subsequently established by the National Nanotechnology Initiative, which defines nanotechnology as the manipulation of matter with at least one dimension sized from 1 to 100 nanometers. This definition reflects the fact that quantum mechanical effects are important at this quantum-realm scale, and so the definition shifted from a particular technological goal to a research category inclusive of all types of research and technologies that deal with the special properties of matter which occur below the given size threshold. It is therefore common to see the plural form "nanotechnologies" as well as "nanoscale technologies" to refer to the broad range of research and applications whose common trait is size.


  • Track 9-1Characterization of Pharmaceutical Nanotools
  • Track 9-2Engineering of Pharmaceutical Nanosystems
  • Track 9-3Future Prospects of Pharmaceutical Nanotechnology
  • Track 9-4Challenges to Pharmaceutical Nanotechnology

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition

  • Track 10-1Design of Nano drugs
  • Track 10-2Drug Targeting and Drug Design
  • Track 10-3Pharmaceutical nanotechnology

Pharmaceutical biotechnology is a relatively new and growing field in which the principles of biotechnology are applied to the development of drugs. Most therapeutic drugs in the current market are bioformulations, such as antibodies, nucleic acid products and vaccines. Such bioformulations are developed through several stages that include: understanding the principles underlying health and disease; the fundamental molecular mechanisms governing the function of related biomolecules; synthesis and purification of the molecules; determining the product shelf life, stability, toxicity and immunogenicity; drug delivery systems; patenting; and clinical trials.


  • Track 11-1Microarray Technology
  • Track 11-2Industrial Biotechnology
  • Track 11-3Vaccines and Antibiotics
  • Track 11-4Biologically inspired Pharmaceutics

Pharmaceutical engineering is a branch of engineering focused on discovering, formulating, and manufacturing medication, as well as analytical and quality control processes. It utilizes the fields of chemical engineering, biomedical engineering, and pharmaceutical sciences.

Pharmaceutical Microbiology is an applied branch of Microbiology. It involves the study of microorganisms associated with the manufacture of pharmaceuticals e.g. minimizing the number of microorganisms in a process environment, excluding microorganisms and microbial biproducts like exotoxin and endotoxin from water and other starting materials, and ensuring the finished pharmaceutical product is sterile. Other aspects of pharmaceutical microbiology include the research and development of anti-infective agents, the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and the use of microorganisms in the manufacture of pharmaceutical products like insulin and human growth hormone.


  • Track 12-1Microorganisms in Pharmaceutical Industry
  • Track 12-2Drug discovery, development and molecular biology
  • Track 12-3Pharmacokinetic and Pharmacodynamic studies

Computers are now a days used in pharmaceutical in industries, hospitals and in various departments for drug information, education, evaluation, analysis, medication history and for maintenance of financial records. They have become indispensable in the development of clinical pharmacy, hospital pharmacy and pharmaceutical research. Computers are also useful for patient profile monitoring, medication, database management and material management. It is useful in providing on drug interactions, drug information services and patient counseling.


  • Track 13-1Computer aided learning
  • Track 13-2Diagnostic laboratories
  • Track 13-3Use of Computers in Hospital Pharmacy
  • Track 13-4Computational modeling of drug disposition
  • Track 13-5Digital Libraries

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms.[1][2] Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.

Quality assurance (QA) is a way of preventing mistakes and defects in manufactured products and avoiding problems when delivering products or services to customers; which ISO 9000 defines as "part of quality management focused on providing confidence that quality requirements will be fulfilled". This defect prevention in quality assurance differs subtly from defect detection and rejection in quality control and has been referred to as a shift left since it focuses on quality earlier in the process (i.e., to the left of a linear process diagram reading left to right).


  • Track 14-1Analytical Techniques
  • Track 14-2Sample handlings
  • Track 14-3Calibration Procedures

Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.


  • Track 15-1Pharmacovigilance and Risk Management
  • Track 15-2Clinical Research and Statistics
  • Track 15-3Pharmacovigilance Significance & Scope
  • Track 15-4Data Quality Management and Analysis

Drug regulation is the control of drug use by international agreement and/or by regulatory authorities such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Japanese Pharmaceutical and Medical Devices Agency (PMDA). This includes regulations concerned with the development, approval, manufacturing and marketing of drugs.

\r\n Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.


\r\n GMP covers all aspects of production from the starting materials, premises, and equipment to the training and personal hygiene of staff. Detailed written procedures are essential for each process that could affect the quality of the finished product. There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process - every time a product is made.



  • Track 17-1Facts about current good manufacturing practices (cGMPs)
  • Track 17-2Good automated manufacturing practice (GAMP)
  • Track 17-3FDA good manufacturing practices
  • Track 17-4GMP/GCP interface & GMP audits
  • Track 17-5GMPs for OTC and cosmetic products – global requirements
  • Track 17-6GMPs for medical devices
  • Track 17-7GMPs for medical devices

The branch of genetics concerned with determining the likely response of an individual to therapeutic drugs. Its name reflects it’s combining of pharmacology and genomics. It deals with the influences such as acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics (drug absorption, distribution, metabolism, and elimination), as well as drug receptor target effects.


  • Track 18-1Molecular epidemiology and its biomarkers
  • Track 18-2Adverse event reporting system
  • Track 18-3Molecular pathological epidemiology
  • Track 18-4Pharmacovigilance and post marketing surveillance

Cost Effectiveness of Medicines (Pharmacoeconomics) examines the economic savings from the use of one drug rather than others, regarding costs for the drug itself and patient management (e.g., compliance, quality of life, physician visits, potential hospitalization).

  • Track 19-1Health Economics
  • Track 19-2Cost-Minimization Analysis
  • Track 19-3Cost-Utility Analysis
  • Track 19-4Pricing and Market Access
  • Track 19-5Quality-Adjusted Life Years
  • Track 19-6Economic Evaluation Of Pharmaceuticals
  • Track 19-7ROI: Return on Investment

The most fundamental goal in drug design is to predict whether a given molecule will bind to a target and if so how strongly. Molecular mechanics or molecular dynamics are most often used to predict the conformation of the small molecule and to model conformational changes in the biological target that may occur when the small molecule binds to it. The therapeutic response of a drug depends upon the interaction of drug molecules with a cell on cell membrane related biological events at receptor sites in a concentration-dependent manner. Selective and effective localization of the pharmacologically active moiety at pre-identified target(s) in therapeutic concentration, while restricting its access to non-target(s) normal cellular linings, thus minimizing toxic effects and maximizing the therapeutic index accounts from effective and efficient drug delivery.

  • Track 20-1Factors influencing drug targeting
  • Track 20-2Advances in drug targeting components
  • Track 20-3Role of computers in drug design: Their success and failure
  • Track 20-4Computer aided drug design
  • Track 20-5Recent approaches to drug targeting

Healthcare is the maintenance or improvement of health via the prevention, diagnosis, and treatment of disease, illness, injury, and other physical and mental impairments in people. Health care is delivered by health professionals in allied health fields. Physicians and physician associates are a part of these health professionals. Dentistry, midwifery, nursing, medicine, optometry, audiology, pharmacy, psychology, occupational therapy, physical therapy and other health professions are all part of health care. It includes work done in providing primary care, secondary care, and tertiary care, as well as in public health.

  • Track 21-1Respiratory Medicine
  • Track 21-2Allergy, Asthma and Immunology treatments
  • Track 21-3Research developments in healthcare
  • Track 21-4Advancements Diagnosis of diseases

Drug regulation is the control of drug use by international agreement and/or by regulatory authorities such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Japanese Pharmaceutical and Medical Devices Agency (PMDA). This includes regulations concerned with the development, approval, manufacturing and marketing of drugs.

  • Track 22-1Drug Safety Training
  • Track 22-2Drug Safety Reporting & Monitoring
  • Track 22-3Drug Safety Services & Softwares